This week’s MedTech deals highlight continued capital momentum across public and private markets, with companies advancing tumor ablation, kidney stone care, and AI-enabled monitoring technologies toward broader clinical adoption. Details follow below.
Alamar Biosciences announces...
This week’s MedTech deals highlight continued capital momentum across public and private markets, with companies advancing tumor ablation, kidney stone care, and AI-enabled monitoring...
AliveCor announced that it received CE mark for its Kardia 12L electrocardiogram (ECG) system.
Mountain View, California-based AliveCor describes it as the world’s first AI-powered,...
Osteoboost Health Inc. has closed an $8 million financing round to scale manufacturing, expand clinical research and broaden commercialization of its FDA-cleared medical device...
Stereotaxis, a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, announced that it has entered into a definitive agreement to...
FeelTect has kicked off a clinical trial in Ireland to evaluate its wearable, pressure-sensing device for vein ulcers.
Researchers at the University of Galway will...
Boston Scientific announced new findings from the CHAMPION-AF trial supporting its Watchman FLX system.
Watchman FLX, Boston Scientific’s left atrial appendage closure (LAAC) device, reduces...
iPerf announced the first-in-human use of its new dual-flow femoral arterial cannula device. Lyon, France-based iPerf designed its device to integrate an additional flow...
Providence Medical Technology has enrolled the first subjects in its prospective, randomised controlled trial (RCT) assessing the CORUS-LX system to treat degenerative lumbosacral disease.
The...
This week’s MedTech deals highlight continued capital momentum across public and private markets, with companies advancing tumor ablation, kidney stone care, and AI-enabled monitoring...
AliveCor announced that it received CE mark for its Kardia 12L electrocardiogram (ECG) system.
Mountain View, California-based AliveCor describes it as the world’s first AI-powered,...
Osteoboost Health Inc. has closed an $8 million financing round to scale manufacturing, expand clinical research and broaden commercialization of its FDA-cleared medical device...
Stereotaxis, a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, announced that it has entered into a definitive agreement to...